.png?width=600&height=192&name=IntegriCell%20Logo_Color%20(3).png)
IntegriCell™ is a standardized cryopreservation and distribution solution for the global Cell Therapy market. The IntegriCell™ solution combines Cryoport’s global leadership in temperature-controlled supply chain solutions with our domestic and international cryopreservation and storage capabilities.
• Ready-to-use leukapheresis cryopreservation protocol (RUO)
• Technology transfer services of clients cryopreservation processes to IntegriCell™ teams
• Customized cryopreservation process development services to meet client needs
• Optimization of cellular viability via cryopreservation within 24 hours postcollection
• Standardization of cryopreservation protocols performed by experienced IntegriCell™ teams
• Manufacturing slot utilization improved with incorporation of cryopreservation
• Global clinical trial coverage through our US and European footprint
Who We Serve• Cell and Gene Therapy Developers • Contract Development Manufacturing Organizations (CDMO) • Clinical Research Organizations (CRO) • Hospitals and Academic Programs • Leukapheresis Providers |
|
A Leap Forward in Standardizing the Regenerative Medicine Supply Chain – What the New ISO 21973 Guidance Means for Cell and Gene Therapy Developers
Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC
